REATA PHARMACEUTICALS INC Annual Depreciation in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Reata Pharmaceuticals Inc quarterly/annual Depreciation history and growth rate from 2015 to 2022.
  • Reata Pharmaceuticals Inc Depreciation for the quarter ending June 30, 2023 was $293K, a 7.33% increase year-over-year.
  • Reata Pharmaceuticals Inc Depreciation for the twelve months ending June 30, 2023 was $1.13M, a 7.6% decline year-over-year.
  • Reata Pharmaceuticals Inc annual Depreciation for 2022 was $1.13M, a 6.07% decline from 2021.
  • Reata Pharmaceuticals Inc annual Depreciation for 2021 was $1.2M, a 5.9% increase from 2020.
  • Reata Pharmaceuticals Inc annual Depreciation for 2020 was $1.14M, a 21.9% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.13M -$73K -6.07% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-24
2021 $1.2M +$67K +5.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
2020 $1.14M +$204K +21.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 $932K +$501K +116% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $431K -$6K -1.37% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $437K -$245K -35.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $682K -$1.14M -62.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $1.82M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.